Similar articles for PMID: 17785355

Year	Number of Results
2002	1
2003	1
2004	7
2005	9
2006	12
2007	17
2008	12
2009	16
2010	13
2011	13
2012	34
2013	36
2014	29
2015	32
2016	31
2017	27
2018	22
2019	15
2020	13
2021	7
2022	6
2024	0

1

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

Lupi C, Giannini R, Ugolini C, Proietti A, Berti P, Minuto M, Materazzi G, Elisei R, Santoro M, Miccoli P, Basolo F. Lupi C, et al. J Clin Endocrinol Metab. 2007 Nov;92(11):4085-90. doi: 10.1210/jc.2007-1179. Epub 2007 Sep 4. J Clin Endocrinol Metab. 2007. PMID: 17785355

2

BRAF V600E and Novel Somatic Mutations in Thyroid Cancer of Libyan Patients.

Tounsi Guettiti H, Traina H, Ben Ayed I, Ben Jemii N, Boubaker S, Alrageeg M, Alqawi O. Tounsi Guettiti H, et al. Asian Pac J Cancer Prev. 2022 Dec 1;23(12):4029-4037. doi: 10.31557/APJCP.2022.23.12.4029. Asian Pac J Cancer Prev. 2022. PMID: 36579983 Free PMC article.

3

Circulating microRNAs and Clinicopathological Findings of Papillary Thyroid Cancer: A Systematic Review.

Geropoulos G, Psarras K, Papaioannou M, Giannis D, Meitanidou M, Kapriniotis K, Symeonidis N, Pavlidis ET, Pavlidis TE, Sapalidis K, Ahmed NM, Abdel-Aziz TE, Eddama MMR. Geropoulos G, et al. In Vivo. 2022 Jul-Aug;36(4):1551-1569. doi: 10.21873/invivo.12866. In Vivo. 2022. PMID: 35738604 Free PMC article. Review.

4

BRAF Mutations in Papillary Thyroid Carcinoma: A Genomic Approach Using Probe-Based DNA Capture for Next-Generation Sequencing.

Smith RA, Lam AK. Smith RA, et al. Methods Mol Biol. 2022;2534:161-174. doi: 10.1007/978-1-0716-2505-7_12. Methods Mol Biol. 2022. PMID: 35670975

5

Risk and Prognostic Factors for BRAF^V600E Mutations in Papillary Thyroid Carcinoma.

Wei X, Wang X, Xiong J, Li C, Liao Y, Zhu Y, Mao J. Wei X, et al. Biomed Res Int. 2022 May 18;2022:9959649. doi: 10.1155/2022/9959649. eCollection 2022. Biomed Res Int. 2022. PMID: 35647194 Free PMC article. Review.

6

Comparative BRAF V600E immunohistochemical expression in differentiated thyroid tumors with papillary features.

Wahid MHA, Almudhafar RH. Wahid MHA, et al. J Med Life. 2022 Apr;15(4):520-525. doi: 10.25122/jml-2021-0415. J Med Life. 2022. PMID: 35646190 Free PMC article.

7

Targeted Therapy in BRAF p.K601E-Driven NSCLC: Case Report and Literature Review.

Saalfeld FC, Wenzel C, Aust DE, Wermke M. Saalfeld FC, et al. JCO Precis Oncol. 2020 Nov;4:1163-1166. doi: 10.1200/PO.20.00187. JCO Precis Oncol. 2020. PMID: 35050775 No abstract available.

8

Unexpected Widespread Bone Metastases from a BRAF K601N Mutated Follicular Thyroid Carcinoma within a Previously Resected Multinodular Goiter.

Repaci A, Salituro N, Vicennati V, Monari F, Cavicchi O, de Biase D, Ciarrocchi A, Acquaviva G, De Leo A, Gruppioni E, Pagotto U, Tallini G. Repaci A, et al. Endocr Pathol. 2022 Dec;33(4):519-524. doi: 10.1007/s12022-021-09698-7. Epub 2021 Nov 29. Endocr Pathol. 2022. PMID: 34843063

9

[Clinicopathological features and molecular characteristics of tall cell and hobnail variants of papillary thyroid carcinoma].

Zhang M, Duan HL, Wang LM, Gao W, Yao YY, Teng LH. Zhang M, et al. Zhonghua Bing Li Xue Za Zhi. 2021 Nov 8;50(11):1234-1239. doi: 10.3760/cma.j.cn112151-20210630-00473. Zhonghua Bing Li Xue Za Zhi. 2021. PMID: 34719160 Chinese.

10

Detection of Circulating Tumor DNA in Patients with Thyroid Nodules.

Patel KB, Cormier N, Fowler J, Partridge A, Theurer J, Black M, Pinto N, Yoo J, Fung K, MacNeil D, Stecho W, Howlett C, Brackstone M, Barrett JW, Nichols A. Patel KB, et al. Int J Endocrinol. 2021 Aug 23;2021:8909224. doi: 10.1155/2021/8909224. eCollection 2021. Int J Endocrinol. 2021. PMID: 34475951 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

303 results

Results by year